Literature DB >> 24136620

Phenotypic consequences in black South African Fanconi anemia patients homozygous for a founder mutation.

Candice Feben1, Jennifer Kromberg2, Rosalind Wainwright3, David Stones4, Chris Sutton5, Janet Poole6, Tabitha Haw1, Amanda Krause1.   

Abstract

PURPOSE: Fanconi anemia is a genotypically and phenotypically heterogeneous condition, characterized microscopically by chromosomal instability and breakage. Affected individuals manifest growth restriction and congenital physical abnormalities; most progress to hematological disease including bone marrow aplasia. Black South African Fanconi anemia patients share a common causative founder mutation in the Fanconi G gene in 80% of cases (637_643delTACCGCC). The aim of this study was to investigate the genotype-physical phenotype correlation in a cohort of individuals homozygous for this mutation.
METHODS: Thirty-five black patients were recruited from tertiary level hematology/oncology clinics in South Africa. Participants were subjected to a comprehensive clinical examination, documenting growth, congenital anomalies, and phenotypic variability.
RESULTS: Descriptive statistical analysis showed significant growth abnormalities in many patients and a high frequency (97%) of skin pigmentary anomalies. Subtle anomalies of the eyes, ears, and hands occurred frequently (≥70%). Apart from malformations of the kidney (in 37%) and gastrointestinal tract (in 8.5%), congenital anomalies of other systems including the cardiovascular and central nervous systems, genitalia, and vertebrae were infrequent (<5%).
CONCLUSION: The diagnosis of Fanconi anemia in black South African patients before the onset of hematological symptoms remains a clinical challenge, with the physical phenotype unlikely to be recognized by those without dysmorphology expertise.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136620     DOI: 10.1038/gim.2013.159

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  5 in total

Review 1.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.

Authors:  Jasmine D Peake; Eishi Noguchi
Journal:  Hum Genet       Date:  2022-05-21       Impact factor: 5.881

2.  Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia.

Authors:  Candice Feben; Careni Spencer; Anneline Lochan; Nakita Laing; Karen Fieggen; Engela Honey; Tasha Wainstein; Amanda Krause
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

3.  Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.

Authors:  Bronwyn Dillon; Candice Feben; David Segal; Johannes du Plessis; David Reynders; Rosalind Wainwright; Janet Poole; Amanda Krause
Journal:  Mol Genet Genomic Med       Date:  2020-06-11       Impact factor: 2.183

4.  Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG.

Authors:  Pedro Reyes; Benilde García-de Teresa; Ulises Juárez; Fernando Pérez-Villatoro; Moisés O Fiesco-Roa; Alfredo Rodríguez; Bertha Molina; María Teresa Villarreal-Molina; Jorge Meléndez-Zajgla; Alessandra Carnevale; Leda Torres; Sara Frias
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

Review 5.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.